SSM Health St Anthony Hospital Obstetrics and Gynecology

Topics

• Ovarian cancer diagnosis and treatment 95
• Endometrial and Cervical Cancer Treatments 73
• PARP inhibition in cancer therapy 71
• Cervical Cancer and HPV Research 15
• HER2/EGFR in Cancer Research 10
• Pelvic floor disorders treatments 8
• Cancer Immunotherapy and Biomarkers 7
• PI3K/AKT/mTOR signaling in cancer 7
• Ovarian function and disorders 6
• Radiomics and Machine Learning in Medical Imaging 6
• Angiogenesis and VEGF in Cancer 5
• Ethics in Clinical Research 5

Most cited

1. Recent advances and clinical applications of deep learning in medical image analysis.

   Medical image analysis · 2022 · 535 citations · Kathleen Moore

2. Mirvetuximab Soravtansine in FRα-Positive, Platinum-Resistant Ovarian Cancer.

   The New England journal of medicine · 2023 · 405 citations · Kathleen Moore

3. Durvalumab Plus Carboplatin/Paclitaxel Followed by Maintenance Durvalumab With or Without Olaparib as First-Line Treatment for Advanced Endometrial Cancer: The Phase III DUO-E Trial.

   Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2024 · 323 citations · Kathleen Moore

4. Overall Survival With Maintenance Olaparib at a 7-Year Follow-Up in Patients With Newly Diagnosed Advanced Ovarian Cancer and a BRCA Mutation: The SOLO1/GOG 3004 Trial.

   Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2023 · 420 citations · Kathleen Moore

5. Neoadjuvant Chemotherapy for Newly Diagnosed, Advanced Ovarian Cancer: ASCO Guideline Update.

   Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2025 · 89 citations · Kathleen Moore

6. A Randomized, Phase III Trial to Evaluate Rucaparib Monotherapy as Maintenance Treatment in Patients With Newly Diagnosed Ovarian Cancer (ATHENA-MONO/GOG-3020/ENGOT-ov45).